Cadherin-N
| GO Term | Evidence Code | PMID |
|---|---|---|
| homophilic cell adhesion via plasma membrane adhesion molecules | ||
| homophilic cell adhesion via plasma membrane adhesion molecules | ||
| axon guidance | ||
| axon guidance | ||
| axon target recognition |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| cell-cell junction | ||
| cell-cell junction |
| GO Term | Evidence Code | PMID |
|---|---|---|
| calcium ion binding | ||
| calcium ion binding | ||
| calcium ion binding | ||
| protein binding | ||
| protein homodimerization activity |
| InterPro |
|---|
| Cadherin conserved site |
| Cadherin, Y-type LIR-motif |
| Cadherin-like superfamily |
| Cadherin-like |
| Cadherin |
| Catenin binding domain superfamily |
| Location | References |
|---|---|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:10283 | prostate cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025